Research Advances on Application of 18F-FDG PET/CT in Clinical Diagnosis and Treatment of Hepatocellular Carcinoma
10.3971/j.issn.1000-8578.2022.21.1416
- VernacularTitle:18F-FDG PET/CT在肝细胞肝癌临床诊疗中的应用进展
- Author:
Shasha XU
1
;
Xingmin HAN
Author Information
1. Department of Nuclear Medicine, The First Affiliated Hospital of Zhengzhou University, Henan Medical Key Laboratory of Molecular Imaging, Zhengzhou 450052, China
- Publication Type:Research Article
- Keywords:
Hepatocellular carcinoma;
18F-FDG PET/CT;
Diagnosis;
Prognosis
- From:
Cancer Research on Prevention and Treatment
2022;49(5):384-471
- CountryChina
- Language:Chinese
-
Abstract:
Hepatocellular carcinoma (HCC) has high mortality, low early diagnosis rate, relatively poor treatment outcomes and prognosis. 18F-FDG PET/CT has an important application value on the detection of HCC metastasis, early recurrence and treatment prognosis. This paper summarizes and reviews the research progress on the application of 18F-FDG PET/CT in HCC diagnosis, liver transplantation, surgical resection and local ablation, to provide references for clinicians to make rational use of 18F-FDG PET/CT imaging technology in accurate diagnosis and treatment of HCC.
